Lecanemab (Leqembi) and Alzheimer’s disease: authorization in France, side effects and indications
© ShutterstockOn January 6, 2023, the Food and Drug Administration (FDA) in the United States approved lecanemabthe second treatment of ...
Read more© ShutterstockOn January 6, 2023, the Food and Drug Administration (FDA) in the United States approved lecanemabthe second treatment of ...
Read more